Related Experiment Videos
Chronobiologic response modifiers and breast cancer development: classical background and chronobiologic tasks
1Chronobiology Laboratories, University of Minnesota, Minneapolis 55455.
In Vivo (Athens, Greece)
|July 1, 1992
Summary
Understanding the body's biological rhythms (chronome) can guide the use of chronobiologic response modifiers (CBRMs) to potentially prevent cancer. CBRMs may help by disrupting synchronized susceptibility peaks that fuel cancer growth.
Area of Science:
- Chronobiology
- Oncology
- Neuroendocrinology
- Immunology
Background:
- The body possesses multi-frequency biological rhythms (daily, weekly, yearly) influencing neuroendocrine and immune functions.
- These rhythms, collectively termed the chronome, play a role in physiological processes and susceptibility to diseases like cancer.
- Cancer development may be influenced by the alignment of susceptibility peaks related to neuroendocrine, immune, and cell cycle functions.
Purpose of the Study:
- To investigate how manipulating biological rhythms using chronobiologic response modifiers (CBRMs) can impact cancer risk.
- To explore the potential of CBRMs in preventing or treating cancer by disrupting synchronized susceptibility peaks.
- To systematically study the effects of internal neuroendocrine shifts on chronome-related susceptibility.
Main Methods:
- Utilizing pituitary/hypothalamic isografts in virus-free Bagg albino mice.
- Employing heterophasic designs to investigate neuroendocrine shifts.
- Analyzing multi-frequency rhythms (circadian, circannual) of neuroendocrine and immune markers.
Main Results:
- Demonstrated that manipulating biological rhythms via CBRMs can alter susceptibility to cancer.
- Identified specific chronome configurations associated with lower cancer risk, such as variations in TSH and prolactin amplitudes.
- Showcased gender-specific differences in favorable chronome configurations for reducing cancer risk.
Conclusions:
- Mapping the chronome's rhythms is crucial for timing the application of CBRMs.
- CBRMs hold potential for cancer prevention and treatment by desynchronizing susceptibility peaks.
- Reproducing favorable chronome configurations may reduce the risk of hormone-related cancers like breast and prostate cancer.